These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11820612)

  • 1. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
    Chrzanowski K; Pałka J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
    Chrzanowski K; Bielawska A; Bielawski K; Wołczyński S; Pałka J
    Farmaco; 2001 Sep; 56(9):701-6. PubMed ID: 11680815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
    Chrzanowski K; Bielawska A; Pałka J
    Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
    Bielawska A; Bielawski K; Pałka J
    Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
    Bielawska A; Chrzanowski K; Bielawski K; Pałka J
    Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
    Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
    Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolidase-activated prodrug for cancer chemotherapy cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells.
    Bielawska A; Bielawski K; Chrzanowski K; Wołczyński S
    Farmaco; 2000; 55(11-12):736-41. PubMed ID: 11204951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
    Mittal S; Song X; Vig BS; Amidon GL
    Pharm Res; 2007 Jul; 24(7):1290-8. PubMed ID: 17377743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylsalicylic acid as a potential regulator of prolidase-convertible pro-drugs in control and neoplastic cells.
    Chrzanowski K; Bielawska A; Bielawski K; Pałka J; Wołczyński S
    Farmaco; 2004 Sep; 59(9):679-84. PubMed ID: 15337432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity activity of L-proline analogues of anthraquinone-2-carboxylic acid in breast cancer MCF-7 cells.
    Bielawska A; Bielawski K; Pałka J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():207-8. PubMed ID: 11820611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolidase as a prodrug converting enzyme I. Synthesis of proline analogue of chlorambucil and its susceptibility to the action of prolidase.
    Bielawska A; Bielawski K; Pałka J
    Rocz Akad Med Bialymst; 1997; 42(1):148-55. PubMed ID: 9581474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule based delivery systems for alkylating antineoplastic compounds.
    Bielawski K; Bielawska A
    ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolidase as a prodrug converting enzyme. II. Synthesis of proline analogue of anthraquinone-2-carboxylic acid and its susceptibility to the action of prolidase.
    Bielawska A; Bielawski K; Pałka J
    Rocz Akad Med Bialymst; 1998; 43():201-9. PubMed ID: 9972056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cytotoxicity and increased antimitotic activity of proline analogue of chlorambucil as a prodrug in breast cancer MCF-7 cells.
    Bielawska A; Chrzanowski K; Bielawski K; Pałka J
    Acta Pol Pharm; 2000 Nov; 57 Suppl():103-5. PubMed ID: 11293233
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells.
    Bielawski K; Bielawska A; Sosnowska K; Miltyk W; Winnicka K; Pałka J
    Biochem Pharmacol; 2006 Jul; 72(3):320-31. PubMed ID: 16730667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proline-linked nitrosoureas as prolidase-convertible prodrugs in human breast cancer cells.
    Bielawski K; Bielawska A; Słodownik T; Bołkun-Skórnicka U; Muszyńska A
    Pharmacol Rep; 2008; 60(2):171-82. PubMed ID: 18443378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
    Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
    J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiproliferative action of a melphalan hexapeptide with collagenase-cleavable site.
    Timár F; Botyánszki J; Süli-Vargha H; Babó I; Oláh J; Pogány G; Jeney A
    Cancer Chemother Pharmacol; 1998; 41(4):292-8. PubMed ID: 9488598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Prolidase Induces Autophagic Death in MCF-7 Breast Cancer Cells.
    Zareba I; Huynh TYL; Kazberuk A; Teul J; Klupczynska A; Matysiak J; Surazynski A; Palka J
    Cell Physiol Biochem; 2020 Sep; 54(5):875-887. PubMed ID: 32918543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
    Wu Z; Shah A; Patel N; Yuan X
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.